Posted in | News | Display | Imaging

3DIcon Files Patent for Virtual Moving Screen

3DIcon Corporation, a development-stage technology company, announced today that its research team at the University of Oklahoma, working under a sponsored research agreement (SRA), has filed a provisional patent application with the U.S. Patent and Trademark Office describing a virtual moving screen for rendering three-dimensional (3D) images.

“This is a breakthrough concept unifying rendering technologies that require a moving screen with those that require a static screen. We are creating platforms that enable Swept Volume Display (SVD)-type rendering engines to project on static screens just like our CSpace-type displays,” stated Hakki Refai, Ph.D, co-principal investigator for 3DIcon’s SRA at OU.

3DIcon Chairman Martin Keating added, “Strategically speaking, this patent further strengthens our intellectual property portfolio and puts us in a more favorable position to license as well as to defend our technologies.”

SVD and other motion-dependent rendering technologies (like full- and half-rotating screens, rotating Archimedes spirals, spiral screens, etc.) require moving screens to create a 3D image. 3DIcon’s new provisional patent describes a virtual moving screen which is compatible with motion-dependent-type engines. The virtual moving screen can receive input from the rendering engine and render images on displays that require no moving parts. Moving parts can restrict the size, color, clarity, and portability of 3D images. This technology offers substantial potential benefits to the 3D imaging industry.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.